Poseida Therapeutics

About Poseida Therapeutics

Poseida Therapeutics (NASDAQ:PSTX) is a biotechnology company focused on the development of innovative cell and gene therapies. Utilizing groundbreaking technology, Poseida seeks to engineer life-saving treatments for patients with cancer and rare diseases. The company's diverse pipeline includes unique approaches to CAR-T therapies for solid tumors and hematological malignancies, alongside cutting-edge gene editing technologies aimed at genetic disorders. With a commitment to advancing medicine and improving lives, Poseida Therapeutics is dedicated to pushing the boundaries of science to deliver new therapies that can address unmet medical needs.

What is Poseida Therapeutics known for?

Snapshot

2014

Year founded

324

Employees

San Diego, United States

Head office

Loading Map...

Operations

All Locations

San Diego, US

Products and/or services of Poseida Therapeutics

Novel gene therapies leveraging non-viral delivery platforms aimed at treating severe genetic diseases, focusing on high precision and safety.
CAR-T programs targeting solid tumors and hematological malignancies, utilizing unique technology for enhanced cancer cell targeting.
In-house T-cell engineering platform to develop off-the-shelf CAR-T therapies, reducing treatment time and cost for patients.
Gene editing tools based on proprietary DNA-cutting enzymes, offering potential for correction of a wide array of genetic disorders.
Liver-directed therapies using non-viral gene delivery techniques for treating metabolic diseases, focusing on improving efficacy and reducing adverse effects.
Partnerships with major pharmaceutical companies to accelerate the development and commercialization of advanced therapies in areas of unmet medical need.